Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Non-Muscle-Invasive Bladder Cancer.
Villegas E, Lajkosz K, Din S, Kuk C, Chan A, Kwong JCC, Vitug C, Gao B, Hemminki O, Kot D, Misurka J, Black P, Jewett M, Soloway MS, Roupret M, Compérat E, Sweet J, Seisen T, Fleshner NE, Wrana J, van der Kwast TH, Kulkarni GS, Zlotta AR. Villegas E, et al. Among authors: comperat e. J Urol. 2024 Oct 29:101097JU0000000000004305. doi: 10.1097/JU.0000000000004305. Online ahead of print. J Urol. 2024. PMID: 39470318
Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal Status.
Neuzillet Y, Raynaud JP, Dreyfus JF, Radulescu C, Rouanne M, Schneider M, Krish S, Rouprêt M, Drouin SJ, Comperat E, Galiano M, Cathelineau X, Validire P, Molinié V, Fiet J, Giton F, Lebret T, Botto H. Neuzillet Y, et al. Among authors: comperat e. Eur Urol Oncol. 2024 Aug 28:S2588-9311(24)00191-3. doi: 10.1016/j.euo.2024.08.003. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39209681
The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non-muscle-invasive Bladder Cancer.
Beijert IJ, Hagberg O, Gårdmark T, Holmberg L, Häggström C, Johnston A, Trail M, Hamid S, Dreyer BA, Padovani L, Garau R, Hasan R, Ahmad I, Hendry D, Compérat EM, Burger M, Rouprêt M, Gontero P, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, Mariappan P, Liedberg F, van Rhijn BWG; BladderBaSe-Consortium; Scot BC Quality OPS Collaborative; Multi-center EAU Non-Muscle-Invasive Bladder Cancer Guidelines Panel Study Consortium on the WHO1973; WHO2004/2016 Classification Systems for Grade. Beijert IJ, et al. Among authors: comperat em. Eur Urol. 2024 Nov;86(5):391-399. doi: 10.1016/j.eururo.2024.08.013. Epub 2024 Aug 29. Eur Urol. 2024. PMID: 39209674 Free article.
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update.
Gontero P, Birtle A, Capoun O, Compérat E, Dominguez-Escrig JL, Liedberg F, Mariappan P, Masson-Lecomte A, Mostafid HA, Pradere B, Rai BP, van Rhijn BWG, Seisen T, Shariat SF, Soria F, Soukup V, Wood R, Xylinas EN. Gontero P, et al. Among authors: comperat e. Eur Urol. 2024 Aug 17:S0302-2838(24)02514-4. doi: 10.1016/j.eururo.2024.07.027. Online ahead of print. Eur Urol. 2024. PMID: 39155194 Review.
519 results